Comprehensive management of paranasal sinus fungus balls: A Young-IFOS consensus statement.

antibiotics computed tomography endoscopy guideline maxillary sinus mycosis

Journal

International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261

Informations de publication

Date de publication:
05 2023
Historique:
revised: 06 09 2022
received: 21 06 2022
accepted: 18 09 2022
medline: 25 4 2023
pubmed: 24 9 2022
entrez: 23 9 2022
Statut: ppublish

Résumé

Paranasal sinus fungus balls (PSFB) are a common form of surgically treatable, noninvasive mycosis. To date, no guidelines have standardized PSFB treatment or management of difficult cases (eg, immunocompromised or fragile patients). The clinical consensus statement presented herein aims to provide a comprehensive management guide to PSFB based on current evidence. A multidisciplinary, international panel of 19 specialists judged statements in 3 rounds of a modified Delphi method survey. Statements encompassed the following PSFB management issues: definition, diagnostic workup; treatment indications and modalities; and follow-up. Otolaryngologists, maxillofacial surgeons, infectious disease specialists, and transplant physicians were considered the target audience. Among the 23 statements, 7 reached strong consensus and 16 reached consensus. Consensus was reached on the definition, diagnosis, and treatment modalities for PSFB. Postoperative follow-up modalities and scenarios with bacterial superinfection were the most debated issues. Until further data are available, these points provide a framework for the management of PSFB. Moreover, PSFB should be considered a noninvasive mycosis that is not necessarily symptomatic or related to odontogenic conditions. Although diagnosis may be incidental, endoscopy and single imaging (computed tomography or magnetic resonance imaging, with distinctive features) are required for diagnosis, whereas contrast medium would allow for differential diagnosis. Although treatment of PSFB should be considered mandatory before sinus augmentation and is recommended for symptomatic patients, immunosuppressed patients, or patients with planned immunosuppression, watchful waiting could be considered for asymptomatic patients with chronic rhinosinusitis who are provided with appropriate advice and assessment.

Sections du résumé

BACKGROUND
Paranasal sinus fungus balls (PSFB) are a common form of surgically treatable, noninvasive mycosis. To date, no guidelines have standardized PSFB treatment or management of difficult cases (eg, immunocompromised or fragile patients). The clinical consensus statement presented herein aims to provide a comprehensive management guide to PSFB based on current evidence.
METHODS
A multidisciplinary, international panel of 19 specialists judged statements in 3 rounds of a modified Delphi method survey. Statements encompassed the following PSFB management issues: definition, diagnostic workup; treatment indications and modalities; and follow-up. Otolaryngologists, maxillofacial surgeons, infectious disease specialists, and transplant physicians were considered the target audience.
RESULTS
Among the 23 statements, 7 reached strong consensus and 16 reached consensus. Consensus was reached on the definition, diagnosis, and treatment modalities for PSFB. Postoperative follow-up modalities and scenarios with bacterial superinfection were the most debated issues.
CONCLUSION
Until further data are available, these points provide a framework for the management of PSFB. Moreover, PSFB should be considered a noninvasive mycosis that is not necessarily symptomatic or related to odontogenic conditions. Although diagnosis may be incidental, endoscopy and single imaging (computed tomography or magnetic resonance imaging, with distinctive features) are required for diagnosis, whereas contrast medium would allow for differential diagnosis. Although treatment of PSFB should be considered mandatory before sinus augmentation and is recommended for symptomatic patients, immunosuppressed patients, or patients with planned immunosuppression, watchful waiting could be considered for asymptomatic patients with chronic rhinosinusitis who are provided with appropriate advice and assessment.

Identifiants

pubmed: 36150088
doi: 10.1002/alr.23093
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

877-885

Informations de copyright

© 2022 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.

Références

Kim YK, Kim HJ, Kim HY, et al. Extrasinonasal infiltrative process associated with a sinonasal fungus ball: does it mean invasive fungal sinusitis. Diagn Interv Radiol. 2016;22(4):347-353.
Fadda GL, Allevi F, Rosso C, et al. Treatment of paranasal sinus fungus ball: a systematic review and meta-analysis. Ann Otol Rhinol Laryngol. 2021;130(11):1302-1310.
Kim JS, So SS, Kwon SH. The increasing incidence of paranasal sinus fungus ball: a retrospective cohort study in two hundred forty-five patients for fifteen years. Clin Otolaryngol. 2017;42(1):175-179.
Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(S29):1-464.
Rosenfeld RM, Nnacheta LC, Corrigan MD. Clinical consensus statement development manual. Otolaryngol Head Neck Surg. 2015;153:S1-S14.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol. 2021;74(9):790-799.
Liu X, Liu C, Wei H, et al. A retrospective analysis of 1,717 paranasal sinus fungus ball cases from 2008 to 2017. Laryngoscope. 2020;130(1):75-79.
deShazo RD, O'Brien M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg. 1997;123(11):1181-1188.
Craig JR, Poetker DM, Aksoy U, et al. Diagnosing odontogenic sinusitis: an international multidisciplinary consensus statement. Int Forum Allergy Rhinol. 2021;11(8):1235-1248.
Assiri AM, Ryu S, Kim JH. Concurrent diagnosis of sinus fungus ball and invasive fungal sinusitis: a retrospective case series. Mycoses. 2021;64(9):1117-1123.
Fadda GL, Succo G, Moretto P, et al. Endoscopic endonasal surgery for sinus fungus balls: clinical, radiological, histopathological, and microbiological analysis of 40 cases and review of the literature. Iran J Otorhinolaryngol. 2019;31(102):35-44.
Bulfamante AM, Pipolo C, D'Agostino FiorenzaU, et al. Spontaneous healing in maxillary fungus ball: beware of asymptomatic patients. Clin Case Rep. 2021;9(4):1865-1869.
Saibene AM, Vassena C, Pipolo C, et al. Odontogenic and rhinogenic chronic sinusitis: a modern microbiological comparison. Int Forum Allergy Rhinol. 2016;6(1):41-45.
Nicolai P, Lombardi D, Tomenzoli D, et al. Fungus ball of the paranasal sinuses: experience in 160 patients treated with endoscopic surgery. Laryngoscope. 2009;119(11):2275-2279.
Castelnuovo P, Gera R, Di Giulio G, et al. Paranasal sinus mycoses. Acta Otorhinolaryngol Ital. 2000;20(1):6-15.
Centre for Evidence-Based Medicine. OCEBM levels of evidence. Accessed: January 3, 2022. Available at: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
Lehmann AE, Raquib AR, Siddiqi SH, et al. Prophylactic antibiotics after endoscopic sinus surgery for chronic rhinosinusitis: a randomized, double-blind, placebo-controlled noninferiority clinical trial. Int Forum Allergy Rhinol. 2021;11(7):1047-1055.

Auteurs

Alberto Maria Saibene (AM)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Otolaryngology Unit, ASST Santi Paolo E Carlo, Department of Health Sciences, Università Degli Studi Di Milano, Milan, Italy.

Fabiana Allevi (F)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Maxillofacial Surgery Unit, ASST Santi Paolo E. Carlo, Department of Health Sciences, Università Degli Studi Di Milano, Milan, Italy.

Christian Calvo-Henriquez (C)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Otolaryngology, Rhinology and Sleep Apnea Unit, Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.

Nicolas Dauby (N)

Department of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles, School of Public Health, Université Libre de Bruxelles & Institute for Medical Immunology, Brussels, Belgium.

Daniele Dondossola (D)

Department of General and Liver Transplant Surgery Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Rémi Hervochon (R)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
ENT Department, Pitié Salpêtrière Hospital, Paris, France.

Jérome R Lechien (JR)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Department of Head and Neck Surgery, Foch Hospital, Paris Saclay University, Paris, France.

David Lobo-Duro (D)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Rhinology, Endoscopic Sinus & Skull Base Surgery, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Luca Giovanni Locatello (LG)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Department of Otorhinolaryngology, Sant'Antonio Abate Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Tolmezzo, Italy.

Antonino Maniaci (A)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Department of Medical, Surgical Sciences and Advanced Technologies G.F. Ingrassia, University of Catania, Catania, Italy.

Giuditta Mannelli (G)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Miguel Mayo-Yáñez (M)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Otorhinolaryngology-Head and Neck Surgery Department, Complexo Hospitalario Universitario A Coruña, A Coruña, Galicia, Spain.
Clinical Research in Medicine, International Center for Doctorate and Advanced Studies, Universidade de Santiago de Compostela, Santiago de Compostela, Galicia, Spain.

Juan Maza-Solano (J)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Rhinology & Skull Base Surgery, ENT Department, University Hospital Virgen Macarena of Sevilla, Sevilla, Spain.

Thomas Radulesco (T)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Service ORL et Chirurgie Cervico-Faciale du Pr Michel, Hôpital de la Conception, Marseille, France.

Neil Tan (N)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Department of Otolaryngology, Royal Cornwall Hospital, Truro, UK.
College of Medicine and Health, University of Exeter Medical School, Exeter, UK.

Camilla Tincati (C)

Infectious Diseases Clinic, Santi Paolo e Carlo Hospital, Department of Health Sciences, University of Milan, Milan, Italy.

Manuel Tucciarone (M)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Department of Otorhinolaryngology and Head and Neck Surgery, Jerez University Hospital, Jerez de la Frontera, Spain.

Luigi Angelo Vaira (LA)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Department of Medical, Surgical and Experimental Sciences, Maxillofacial Surgery Operative Unit, University of Sassari, Sassari, Italy.

Leigh Sowerby (L)

Young Otolaryngologists-International Federation of Otorhinolaryngological Societies, Paris, France.
Department of Otolaryngology, Western University, London, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH